This is a correction from the publisher of the article Targeting of HIF2-driven cachexia in kidney cancer. The publication was published in the journal Nature Medicine online on January 28, 2026 with DOI 10.1038/s41591-026-04236-6. The correction is related to the topic HIF2-induced cachexia induction in renal cancer. Cachexia is a condition of severe muscle wasting and weakness in cancer patients. HIF2 is a protein that promotes this process in kidney cancer. The aim of the correction is to ensure the accuracy of information about the mechanism and possible therapies. No other specific details or changes are mentioned in the provided content.